Synchron receives FDA approval to begin early feasibility study of their endovascular, brain-computer interface device.

Jason J. Han
DOI: https://doi.org/10.1111/aor.14049
2021-08-19
Artificial Organs
Abstract:Stentrode by Synchron is an endovascularly implanted brain computer interface platform that can relay the activities from the motor cortices of paralyzed patients, potentially offering a relatively noninvasive option for more than five million people in the United States alone.
Engineering,Medicine
What problem does this paper attempt to address?